Illumina price target raised to $105 from $100 at JPMorgan

JPMorgan raised the firm’s price target on Illumina (ILMN) to $105 from $100 and keeps a Neutral rating on the shares. The company reported a “beat and raise” Q3, the analyst tells investors in a research note.